Bristol-myers Squibb Company Stock Forecast

Hold candidate since Nov 17, 2025

The Bristol-Myers Squibb Company stock price gained 1.34% on the last trading day (Monday, 17th Nov 2025), rising from 40.41€ to 40.95€. During the last trading day the stock fluctuated 2.04% from a day low at 40.13€ to a day high of 40.95€. The price has risen in 7 of the last 10 days and is up by 3.02% over the past 2 weeks. Volume fell on the last day by -6 thousand shares and in total, 9 thousand shares were bought and sold for approximately 358.31€ thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.86% during the next 3 months and, with a 90% probability hold a price between 35.35€ and 41.47€ at the end of this 3-month period.

BRM.F Signals & Forecast

The Bristol-Myers Squibb Company stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately 41.31€. On a fall, the stock will find some support from the long-term average at approximately 39.04€. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, November 13, 2025, and so far it has fallen -4.17%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The stock had a Golden Star Signal on Tuesday, September 09, 2025 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Bristol-Myers Squibb Company stock

Bristol-Myers Squibb Company finds support from accumulated volume at 40.41€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved 0.82€ between high and low, or 2.04%. For the last week the stock has had daily average volatility of 2.97%.

Our recommended stop-loss: 39.06€ (-4.62%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (BRM.F) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Bristol-Myers Squibb Company to open at 40.68€, and during the day (based on 14 day Average True Range), to move between 40.45€ and 41.45€, which gives a possible trading interval of +/-1.00€ (+/-2.48%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 2.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 40.99€ (0.09%) than the support at 40.41€ (1.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bristol-Myers Squibb Company stock A Buy?

Bristol-Myers Squibb Company holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.502 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - 40.68€ ( 0.667%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk